← Open Payments lookup

DEANNA WEIBEL: Open Payments

NPI 1417071747 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,272 in 97 payments from 17 companies in 2025. Trend: 2023 $1,927 · 2024 $1,425 · 2025 $2,272

Food & beverage: $2,223Education: $49
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.14$417
GlaxoSmithKline, LLC.15$241
GENZYME CORPORATION10$229
Takeda Pharmaceuticals U.S.A., Inc.11$200
ARS Pharmaceuticals Operations, Inc.3$181
CSL Behring7$177
AstraZeneca Pharmaceuticals LP7$152
Novartis Pharmaceuticals Corporation9$143
Galderma Laboratories, L.P.1$136
Amgen Inc.4$91

Products named: DUPIXENT, NEFFY, XOLAIR, TRELEGY ELLIPTA, CUVITRU, NEMLUVIO, FASENRA, NUCALA.

Industry payments across TX — which companies pay providers there.